The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.
Biogen and Capsigen, a Vancouver, Washington-based gene-therapy company, have entered into a strategic research collaboration to develop gene therapies for central nervous system (CNS) and neuromuscular disorders, in a deal worth up to $1.3 billion...
Roivant Sciences, a New York-based bio/pharmaceutical and healthcare technology company, and Montes Archimedes Acquisition Corp. (MAAC), a special purpose acquisition company (SPAC) sponsored by Patient Square Capital, have formed a merger...
The Biden Administration has issued support for a proposal to temporarily waive intellectual property (IP) rights for COVID-19 vaccines as a means to increase vaccine access in developing countries, a position supported by the World Health...
A roundup of news from Canada (AbCellera), Germany (Merck KGaA and MoonLake Immunotherapeutics), and the US (Pfizer, Sanofi, and Acella Pharmaceuticals).
Canada
AbCellera Breaks Ground on New Global HQ AbCellera, a Vancouver, British Columbia,...
Teva Pharmaceutical Industries, Eli Lilly and Company, and Viatris, the new company formed from the combination of Mylan and Upjohn, Pfizer’s off-patent branded and generic established medicines business, have outlined environmental, social, and...
The US Food and Drug Administration (FDA) has issued a new report outlining the agency’s inspection activities during the COVID-19 pandemic and detailing a plan for future inspection activity, including the FDA’s priorities going forward.
In March...
The latest on COVID-19 vaccines/drugs and manufacturing from Lilly, Pfizer, Novavax, CSL, Sinovac, and Sinopharm.
Manufacturing and supply of COVID-19 vaccines and drugs
Lilly To Accelerate Availability of COVID-19 Drugs in India Eli Lilly and...
Moderna, a biopharmaceutical company developing messenger RNA (mRNA) therapeutics and vaccines, has entered into separate agreements with Gavi, a global vaccine alliance, to supply up to 500 million doses of its COVID-19 vaccine and, up to 14...
Moderna, a biopharmaceutical company developing messenger RNA (mRNA) therapeutics and vaccines, has announced an expansion of its manufacturing technology center in Norwood, Massachusetts by more than doubling production and lab space.
The...
Moderna, a biopharmaceutical company developing messenger RNA (mRNA) therapeutics and vaccines, reports that it is making new funding commitments to increase supply of its COVID-19 vaccine at its owned and partnered manufacturing facilities to be...
The US government is looking at options to provide US-made doses of AstraZeneca’s COVID-19 vaccine to India and is funding an expansion of manufacturing capacity for Biological E. Limited (BioE), a Hyderabad, India based vaccine and pharmaceutical...
The European Commission is working with Pfizer and BioNTech, a Mainz, Germany-based immunotherapy company, on a new contract for their COVID-19 vaccine with the aim to deliver 1.8 billion doses to the European Union (EU) for 2021 to 2023.
“The...
The US Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) have lifted a pause on the rollout of Johnson & Johnson’s (J&J) COVID-19 vaccine in the US and recommended that the rollout of the vaccine...
The latest on COVID-19 vaccines/drugs and manufacturing from AstraZeneca, Merck & Co., Gilead Sciences, Dr. Reddy’s, Valneva, Inovio, and others.
Manufacturing and supply of COVID-19 vaccines and drugs
AstraZeneca Responds to EU’s Legal...
Sanofi has entered into an agreement with Moderna, a biopharmaceutical company developing messenger RNA (mRNA) therapeutics and vaccines, to provide fill–finish sterile manufacturing services and supply packaging for Moderna’s COVID-19 vaccine in...
